BioMarin Pharmaceutical, Inc.
(NASDAQ : BMRN)

( )
BMRN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.28%60.920.0%$915.58m
NVAXNovavax, Inc. 2.19%106.85102.0%$843.89m
AMGNAmgen, Inc. -1.21%253.151.3%$733.54m
REGNRegeneron Pharmaceuticals, Inc. 2.13%654.502.5%$702.41m
GILDGilead Sciences, Inc. -0.13%76.321.0%$675.67m
BIIBBiogen, Inc. -0.54%268.351.6%$573.84m
VRTXVertex Pharmaceuticals, Inc. 0.31%300.001.9%$524.61m
ILMNIllumina, Inc. -1.92%372.123.5%$297.26m
ALXNAlexion Pharmaceuticals, Inc. -0.98%112.462.0%$230.21m
BMRNBioMarin Pharmaceutical, Inc. -0.16%127.774.3%$212.31m
SGENSeattle Genetics, Inc. 3.34%176.146.1%$207.80m
SRNESorrento Therapeutics, Inc. 0.27%7.401.8%$195.70m
IMMUImmunomedics, Inc. 1.30%41.1611.0%$178.10m
SRPTSarepta Therapeutics, Inc. 0.25%163.8913.9%$167.23m
INCYIncyte Corp. 0.80%108.652.5%$166.01m

Company Profile

BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.